Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Rang in Aktien #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Aktienkurs
$4.00
Zuletzt synchronisiert: 2026-08-20
Marktkapitalisierung
$75.37M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
12.99%
Land
US
Handel RetinalGenix Technologies Inc. (RTGN)

Kategorie

Aktien-Split-Historie für RetinalGenix Technologies Inc. (RTGN)
Die Aktie RetinalGenix Technologies Inc. (Symbol: RTGN) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 22, 2026 statt.
Eine RTGN-Aktie, die vor dem Aug 22, 2026 gekauft wurde, entspricht heute 0 RTGN-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE